Blogs about: He3235
Featured Blog
The Tuesday news report: January 27, 2009
Today’s news deals with such items as: Toxicities associated with hypofractionated, intensity-modulated radiation therapy Incidental prostate cancer in male patients undergoing radical cystopro… more →
THE "NEW" PROSTATE CANCER INFOLINK
The Tuesday news report: January 27, 2009
Sitemaster wrote 5 months ago: Today’s news deals with such items as: Toxicities associated with hypofractionated, intensity … more →
Additional Positive Findings For APOPTONE (HE3235) In Preclinical Models Of Castration-Resistant Prostate Cancer
healtherm2 wrote 6 months ago: Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today presented new findings that suggest APOPTONE … more →
The prostate cancer news for Thursday, July 30
Sitemaster wrote 11 months ago: News items today are focused on information about: a new way of approaching treatment of hormone-re … more →
Hollis-Eden initiate Phase I/II trial of Apoptone in Prostate Cancer
crimsoncanary wrote 11 months ago: Hollis-Eden has commenced a Phase I/II clinical trial with its oral drug candidate Apoptone (HE3235 … more →
Have your say. Start a blog.
See our free features →
An 
Experiment
